Key learning points: revised NICE guidance on ME/CFS
Dr David Strain defines best practice management of the chronic, poorly understood condition ME in six key learning points
Epilepsy in children and young people: what is the role of primary care?
Dr Alix Rolfe explores the updated Scottish Intercollegiate Guidelines Network recommendations on epilepsy in children and young people
Top tips: ADHD in children and young people
Dr Natasha Halliwell offers 10 top tips on the identification and management of attention deficit hyperactivity disorder in children and young people
Key learning points: NICE cannabis-based medicinal products
Dr David Spraggett outlines five key learning points to take away from the 2019 NICE guideline on cannabis-based medicinal products
Key learning points: BAP insomnia and sleep disorders
Professor Niroshan Siriwardena highlights the relevant recommendations for primary care from the British Association of Psychopharmacology guideline on insomnia and sleep disorders
Educational resources
Ipinnia® XL (ropinirole hydrochloride) prolonged-release tablets
This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-IPN-13 Date of preparation: September 2021